Premium
Self‐expandable valve‐in‐valve treatment for failing sutureless aortic bioprosthesis
Author(s) -
Belluschi Igor,
Buzzatti Nicola,
Blasio Andrea,
Romano Vittorio,
De Bonis Michele,
Castiglioni Alessandro,
Montorfano Matteo,
Alfieri Ottavio
Publication year - 2020
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.14365
Subject(s) - medicine , regurgitation (circulation) , aortic valve replacement , stenosis , aortic valve , surgery , prosthesis , gold standard (test) , degeneration (medical) , balloon , heart valve , aortic valve stenosis , cardiology , pathology
Aortic valve replacement still represents the gold standard treatment for severe symptomatic aortic stenosis. Sutureless bioprostheses have been so far developed to enhance the minimally invasive approach, resulting in a reduction of cross‐clamp time. Even if the first implantation was carried out more than 10 years ago, some cases of valve degeneration treated with balloon‐expandable valve‐in‐valve procedures have been previously described in the literature. Here, we present a case of early sutureless valve degeneration resulting in severe aortic regurgitation. After careful evaluation of the patient's comorbidities, a successful valve‐in‐valve was finally performed using a self‐expandable transcatheter prosthesis. A wide discussion of the Heart Team decision‐making process and of the technical aspects has been addressed.